Fibrillation and Defibrillation

颤动和除颤

基本信息

项目摘要

The goal of this revised application is to study the relationships between intracellular Ca (Cai) dynamics and the mechanisms of ventricular fibrillation (VF) and defibrillation. In the present funding period, we discovered that Cai dynamics and spontaneous diastolic sarcoplasmic reticulum (SR) Ca release are important to the initial defibrillation success or failure. Whether or not Cai dynamics play a role in the recurrent spontaneous VF after initial successful defibrillation remains unclear. Spontaneous VF episodes are known to occur frequently during cardiopulmonary resuscitation and in patients with VF storms. Preliminary studies from the laboratory of SR Wayne Chen suggested that store overload induced Ca release (SOICR) is an important mechanism of spontaneous SR Ca release. They also found that carvedilol and its analog (VK-II-36) can effectively reduce the sensitivity of type 2 ryanodine receptor (RyR2) to luminal Ca and suppress SR Ca release in rat ventricular myocytes. These findings suggest that inhibition of SOICR may provide a novel approach to improve defibrillation efficacy and prevent postshock spontaneous VF. However, SOICR may not be the only mechanism for postshock arrhythmias. Our preliminary studies showed that late phase 3 EAD may also play a role in postshock arrhythmias in failing and ischemic hearts. The late phase 3 EAD occurs because of the coexistence of shortened action potential duration (APD) and persistently elevated Cai. This Cai elevation is induced by Ca induced Ca release, not SOICR. If late phase 3 EAD is an important mechanism for postshock arrhythmias, then SOICR inhibition alone may not achieve antiarrhythmic effects in the postshock period. We hypothesize that (1) Spontaneous (non-voltage gated) SR Ca release and late phase 3 EAD are both important mechanisms for the development of the postshock arrhythmias and (2) Inhibition of SOICR can improve initial efficacy of ventricular defibrillation and prevent recurrent SVF after successful defibrillation attempts. We will perform dual optical mapping of Cai and membrane potential (Vm) on rabbit ventricular endocardium to document SOICR-induced delayed after depolarization in normal ventricles and in ischemic ventricles. We will also study the effects of VK-II-36, a SOICR inhibitor, on postshock arrhythmias. These studies will provide us new insights into the mechanisms of VF and defibrillation, and help test the hypothesis that inhibition of SOICR is a novel approach to arrhythmia control.
此修订应用程序的目标是研究细胞内 Ca (Cai) 动力学与心室颤动 (VF) 和除颤机制之间的关系。在目前的资助期间,我们发现Cai动力学和自发舒张肌浆网(SR)Ca释放对于初始除颤的成功或失败很重要。蔡动力学是否在初次成功除颤后复发的自发性室颤中发挥作用仍不清楚。据了解,自发性室颤发作在心肺复苏期间和室颤风暴患者中经常发生。 SR Wayne Chen 实验室的初步研究表明,储存超载诱导的 Ca 释放(SOICR)是自发 SR Ca 释放的重要机制。他们还发现卡维地洛及其类似物(VK-II-36)可以有效降低2型兰尼碱受体(RyR2)对管腔Ca的敏感性,并抑制大鼠心室肌细胞中SR Ca的释放。这些发现表明,抑制 SOICR 可能提供一种提高除颤效果和预防电击后自发性心室颤动的新方法。然而,SOICR 可能不是休克后心律失常的唯一机制。我们的初步研究表明,晚期 3 期 EAD 也可能在心脏衰竭和缺血性休克后心律失常中发挥作用。晚期 3 期 EAD 的发生是由于动作电位持续时间 (APD) 缩短和 Cai 持续升高并存。这种 Cai 升高是由 Ca 诱导的 Ca 释放引起的,而不是 SOICR。如果晚期 3 期 EAD 是电击后心律失常的重要机制,那么单独抑制 SOICR 可能无法在电击后阶段达到抗心律失常作用。我们假设 (1) 自发(非电压门控)SR Ca 释放和晚期 3 期 EAD 都是电击后心律失常发生的重要机制;(2) 抑制 SOICR 可以提高心室除颤的初始疗效,并防止成功除颤后复发 SVF。我们将对兔心室心内膜进行 Cai 和膜电位 (Vm) 的双重光学测绘,以记录 SOICR 诱导的正常心室和缺血性心室除极后延迟。我们还将研究 SOICR 抑制剂 VK-II-36 对休克后心律失常的影响。这些研究将为我们提供对 VF 和除颤机制的新见解,并有助于检验抑制 SOICR 是一种控制心律失常的新方法这一假设。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PENG-SHENG CHEN其他文献

PENG-SHENG CHEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PENG-SHENG CHEN', 18)}}的其他基金

Using electrical nerve stimulation to control atrial fibrillation
使用电神经刺激来控制心房颤动
  • 批准号:
    10397354
  • 财政年份:
    2020
  • 资助金额:
    $ 38.5万
  • 项目类别:
Using electrical nerve stimulation to control atrial fibrillation.
使用电神经刺激来控制心房颤动。
  • 批准号:
    9807603
  • 财政年份:
    2019
  • 资助金额:
    $ 38.5万
  • 项目类别:
SK current and ventricular arrhythmias.
SK 电流和室性心律失常。
  • 批准号:
    10164095
  • 财政年份:
    2017
  • 资助金额:
    $ 38.5万
  • 项目类别:
Subcutaneous nerve stimulation for arrhythmia control.
皮下神经刺激可控制心律失常。
  • 批准号:
    9405146
  • 财政年份:
    2017
  • 资助金额:
    $ 38.5万
  • 项目类别:
SK Current, beta-3 adrenoceptor activation and Sex Differences in Ventricular Arrhythmogenesis
SK 电流、β3 肾上腺素受体激活和室性心律失常发生的性别差异
  • 批准号:
    10734708
  • 财政年份:
    2017
  • 资助金额:
    $ 38.5万
  • 项目类别:
Autonomic Nerve Activity and Paroxysmal Atrial Fibrillation
自主神经活动与阵发性心房颤动
  • 批准号:
    7822294
  • 财政年份:
    2009
  • 资助金额:
    $ 38.5万
  • 项目类别:
WAVE DYNAMICS IN NORMAL AND DISEASED RABBIT HEARTS
正常和患病兔心脏中的波动力学
  • 批准号:
    7108467
  • 财政年份:
    2005
  • 资助金额:
    $ 38.5万
  • 项目类别:
Fibrillation and Defibrillation
颤动和除颤
  • 批准号:
    7171857
  • 财政年份:
    2005
  • 资助金额:
    $ 38.5万
  • 项目类别:
Fibrillation and Defibrillation
颤动和除颤
  • 批准号:
    7500776
  • 财政年份:
    2005
  • 资助金额:
    $ 38.5万
  • 项目类别:
Fibrillation and Defibrillation
颤动和除颤
  • 批准号:
    7012199
  • 财政年份:
    2005
  • 资助金额:
    $ 38.5万
  • 项目类别:

相似海外基金

DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
  • 批准号:
    495592
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
  • 批准号:
    23K14885
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
  • 批准号:
    10668025
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
  • 批准号:
    23K09597
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
  • 批准号:
    514892030
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
    WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
  • 批准号:
    10638497
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
  • 批准号:
    10722857
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
  • 批准号:
    10724935
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
  • 批准号:
    10727929
  • 财政年份:
    2023
  • 资助金额:
    $ 38.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了